Camptothecin and taxol: Discovery to clinic
โ Scribed by Monroe E. Wall
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 193 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0198-6325
No coin nor oath required. For personal study only.
โฆ Synopsis
Camptothecin (CPT) is a pentacyclic alkaloid isolated from wood and bark of Camptotheca acuminata. Initially it was found to be highly active in a number of mouse in vivo cancer assays. Subsequently, CPT was found to uniquely inhibit an enzyme, topoisomerase I, which is involved in DNA replication. A number of CPT analogs are in advanced clinical trial, and two, Topotecan and CPT-11, have been approved for marketing by the FDA. taxol, a taxane alkaloid, was isolated from Taxus brevifolia. Taxol is a highly cytotoxic compound active in several mouse antitumor assays. It was subsequently found to uniquely inhibit tubulin, a protein involved in mitosis. After clinical evaluation, it has become the drug of choice for treatment of ovarian cancer.
๐ SIMILAR VOLUMES
The discovery and development of paclitaxel, which covered a time span of some 30 years, has provided some important lessons for those involved in natural product drug discovery and development. These include the adoption of novel screens as they become available, the elucidation of mechanisms of ac